Enliven Therapeutics shares owned by Morgan Stanley
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enliven Therapeutics by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $5.1M | 255k | 20.06 |
| 2024-12-31 | $2.5M | 111k | 22.50 |
| 2024-09-30 | $3.5M | 135k | 25.54 |
| 2024-06-30 | $1.6M | 68k | 23.37 |
| 2024-03-31 | $1.1M | 63k | 17.59 |
| 2023-12-31 | $1.1M | 80k | 13.84 |
| 2023-09-30 | $464k | 34k | 13.66 |
| 2023-06-30 | $680k | 33k | 20.41 |